24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Teva
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:39
Full list of Israeli high-tech layoffs in 2026
21:36
Remitly cuts 110 jobs in Israel and closes R&D hub three years after $80 million Rewire acquisition
16:41
Rigas: "Energean needs more gas to compete, and to prevent a monopoly"
16:31
“When you raise walls around data, employees go around them”
More stories
Buzz
Most popular
Daily
Weekly
1
Chinese fund: “The Chinese government has imposed a ban on any new investment in Israel”
2
Israeli defense firms target Asia as Singapore Airshow opens amid regional arms race
3
Medtronic to acquire Israeli AI cardiology firm CathWorks for $585 million, deal could reach $1 billion
4
After $400M cyber exit, ex-IntSights CEO raises $11M to build AI app for personalized sports highlights
5
“SaaS is dying as a business category”
More news
Teva
20 stories about Teva
Teva to Repay Due Loans with Junk Bond Private Offering
01.03.18
|
Lilach Baumer
The debt-laden generic drugmaker is offering around $3.5 billion in senior notes in both dollar and euro denominations
CTech’s Weekly Israeli Tech News Roundup
23.02.18
|
CTech
Intel plans to expand chip manufacturing in Israel with $5 billion investment. Latest venture by Mobileye founders valued at $1 billion. Intel leads $50 million investment in public transit app Moovit.
Teva Shut Down New York, Washington Offices, Says CEO
23.02.18
|
Dror Reich
In a meeting with investors in Israel, CEO Kåre Schultz said the Washington offices were used mainly by lobbyists, for which Teva has no further need
CTech’s Daily Israeli Tech News Roundup
21.02.18
|
CTech
Intel plans to expand chip manufacturing in Israel with $5 billion investment. Intel leads $50 million investment in public transit app Moovit
Teva No Longer Provides Timeline for Recovery
21.02.18
|
Uri Tal-Tenne
In 2017, the company said it expected moderate growth in operating profits in the U.S. in 2020
Drugmaker Hikma Appoints Former Teva Executive as CEO
20.02.18
|
Asaf Shalev
The appointment of Sigurdur Olafsson comes as Hikma has been struggling to bolster the performance of its generic drugs unit
CTech’s Daily Israeli Tech News Roundup
18.02.18
|
CTech
Teva turns to meritocracy as part of turnaround plan. On way to crypto offering, copyright protection startup makes misleading claims. Israel could be seeing lower corporate tax rate soon
Teva Turns to Meritocracy as Part of Turnaround Plan
18.02.18
|
Dror Reich
A new policy the company is rolling out would see Teva employees compensated according to key performance indicators
CTech’s Weekly Israeli Tech News Roundup
16.02.18
|
CTech
eBay unveils personalized fashion design AI. Israel’s asylum seekers and tech allies speak out against deportation order
CTech’s Daily Israeli Tech News Roundup
15.02.18
|
CTech
Warehouse robotics startup CommonSense Robotics raises $20 million. From eye-tracking to break-up monitoring, love tech can be the next big thing
Berkshire Hathaway Takes Position in Generic Drugmaker Teva
15.02.18
|
Lilach Baumer
The holding company disclosed a $358 million stake in the struggling company
Teva Executive Calls Company’s Fourth Quarter “Fairly Good”
11.02.18
|
Dror Reich
Following the publication of the company's reports, S&P Global downgraded Teva’s corporate credit rating to junk bonds
CTech’s Weekly Israeli Tech News Roundup
09.02.18
|
CTech
Alibaba partners with Israeli startup to supply a cloud database in China. Battery closes two new funds worth $1.25 billion. Israel lowers tax on international venture capital funds
CTech’s Daily Israeli Tech News Roundup
08.02.18
|
CTech
Israeli Prime Minister Says Government Should Avoid Moves to Shore Up Dollar. Generic drugmaker Teva says profit will continue to drop in 2018.
Generic Drugmaker Teva Says Profit Will Continue to Drop in 2018
08.02.18
|
Dror Reich
Israel’s Teva reports a $17-billion goodwill impairment citing the decline of the U.S. generic market
CTech’s Daily Israeli Tech News Roundup
04.02.18
|
CTech
Playtika to hire 100 employees, lease space at Israel’s tallest office tower. Danish Leo Pharma is launching an innovation lab in Israel
Teva Gets Fresh Cash, Fresh Woes
04.02.18
|
Dror Reich
After the troubled drugmaker finalized two deals that will enable it to repay some of its debt, S&P placed it on CreditWatch negative on Friday
CTech’s Daily Israeli Tech News Roundup
23.01.18
|
CTech
BioCanCell raises $25 million. Israel lags behind most developed countries on the Inclusive Development Index. Activist investor Jana Partners takes stake in Teva
Activist Investor Jana Partners Takes Stake in Teva, Report Says
23.01.18
|
Lilach Baumer
The firm has taken a position in the troubled drugmaker during the fourth quarter of 2017, believing CEO Kåre Schultz's cost-cutting measures could turn the company around, according to a Bloomberg report
CTech’s Daily Israeli Tech News Roundup
15.01.18
|
CTech
Hurt by strong shekel, Israeli tech companies lobby for government action. Elbit nearing acquisition of Israeli arms manufacturer IMI Systems. Renault-Nissan-Mitsubishi establishes a $1 billion venture fund
Previous Articles
More Articles